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Introduction {#sec001}
============

A defining feature of animal behavior is its plasticity. Animals adapt their behavior in order to respond to environmental challenges and physiological changes. Such behavioral plasticity is essential for animal survival and is achieved by changing the activity of neurons and circuits in a variety of ways. One way is through neuromodulation, whereby diffusible signals such as neuropeptides, dopamine, and serotonin are used to tune brain activity in broad regions \[[@pgen.1008341.ref001]--[@pgen.1008341.ref003]\]. By contrast, neuronal activity can be altered locally by changing the strength of individual synapses \[[@pgen.1008341.ref004], [@pgen.1008341.ref005]\]. In order to understand dynamic brain function, it is crucial to uncover mechanisms that drive neuroplasticity at various levels.

Electrical synapses (also known as gap junctions) are composed of membrane channels that join the cytoplasm of two cells \[[@pgen.1008341.ref006]\]. They are found throughout vertebrate and invertebrate nervous systems \[[@pgen.1008341.ref006]--[@pgen.1008341.ref009]\] where they pass both electrical and chemical signals between connected cells \[[@pgen.1008341.ref010]\]. Electrical synapses have been primarily studied for their ability to synchronize electrical activity between pairs or groups of neurons \[[@pgen.1008341.ref011]--[@pgen.1008341.ref013]\], but can also pass small molecules such as calcium \[[@pgen.1008341.ref014], [@pgen.1008341.ref015]\], cAMP \[[@pgen.1008341.ref016]--[@pgen.1008341.ref019]\], cGMP \[[@pgen.1008341.ref017], [@pgen.1008341.ref020]\], IP~3~ \[[@pgen.1008341.ref015], [@pgen.1008341.ref021]\], and even small miRNA \[[@pgen.1008341.ref022], [@pgen.1008341.ref023]\]. Interestingly, while electrical synapses share similar function and protein topology in vertebrates and invertebrates \[[@pgen.1008341.ref024]\], genes encoding electrical synapse components are evolutionarily unrelated \[[@pgen.1008341.ref006], [@pgen.1008341.ref010]\]. As a result, electrical synapses in vertebrates are composed of connexins, while those in invertebrates are composed of innexins (INXs). The separate evolution of electrical synapses suggests the functional necessity of these channels, although their role in neural plasticity and brain function is not fully understood.

Recently, it was discovered that innexin networks play a crucial role in cGMP-dependent sensory modulation in *Caenorhabditis elegans* \[[@pgen.1008341.ref025]\]. Krzyzanowski and colleagues found that cGMP functions within the sensory neuron ASH to dampen nociceptive sensitivity but is produced in neighboring neurons \[[@pgen.1008341.ref026]\]. They further showed that cGMP-mediated dampening of ASH nociceptive sensitivity requires an innexin-based network \[[@pgen.1008341.ref025]\]. These findings uncover a new strategy of network regulation that may contribute to the modulation of neural activity. ASH is the primary nociceptive neuron pair in *C*. *elegans* and responds with increased calcium levels to diverse aversive stimuli including hyperosmolarity, nose touch, heavy metals such as copper, volatile repellents such as octanol and alkaloids such as quinine \[[@pgen.1008341.ref027]--[@pgen.1008341.ref033]\]. ASH controls movement away from noxious stimuli through synapses on the forward and backward command interneurons \[[@pgen.1008341.ref034], [@pgen.1008341.ref035]\]. Nociception in ASH is extensively modulated, and reactivity to aversive stimuli such as quinine is regulated by the presence of food and the satiety state of the worm \[[@pgen.1008341.ref025], [@pgen.1008341.ref036]--[@pgen.1008341.ref040]\]. Notably, ASH forms electrical synapses with multiple other sensory neurons and a few interneurons \[[@pgen.1008341.ref041], [@pgen.1008341.ref042]\], suggesting electrical synapses may be crucial in modulating its activity.

We investigated the impact of electrical synapses between ASH and its neighbor ASK on behavioral sensitivity to the bitter tastant quinine. ASK forms multiple electrical synapses with ASH \[[@pgen.1008341.ref042]\] and expresses several innexins \[[@pgen.1008341.ref008], [@pgen.1008341.ref043], [@pgen.1008341.ref044]\], making it a candidate for directly modifying ASH activity. Results of this study show that the electrical synapse proteins INX-18 and INX-19 function within ASK and ASH to allow for modulation of the quinine avoidance response. Through imaging, we found that INX-18 and INX-19 localize to known sites of electrical synapses. Our data further suggest that INX-19 plays a principle role in diffusion of cGMP from ASK to ASH. Our study identifies a direct connection between two sensory neurons that modulates neuronal activity and thus regulates behavior in *C*. *elegans*.

Results {#sec002}
=======

Innexin-18 and innexin-19 are required for modulation of the quinine response {#sec003}
-----------------------------------------------------------------------------

A recent study suggests that a network of electrical synapses is involved in modulation of the quinine response \[[@pgen.1008341.ref025]\], however the exact composition of those electrical synapses has not been determined. ASH is a multimodal nociceptive neuron that responds to quinine and forms direct electrical synaptic connections with the sensory neuron ASK \[[@pgen.1008341.ref041], [@pgen.1008341.ref042]\], which is also involved in quinine sensation \[[@pgen.1008341.ref032]\]. To explore whether the electrical synapses between ASK and ASH play a role in modulating quinine sensitivity, we investigated the innexins INX-18 and INX-19 that are expressed in these two sensory neurons \[[@pgen.1008341.ref008], [@pgen.1008341.ref043], [@pgen.1008341.ref044]\]. While INX-4 is also expressed in ASH, we did not include it in our analyses as it has already been explored in a previous study \[[@pgen.1008341.ref025]\].

To determine whether INX-18 and/or INX-19 play a role in modulating the behavioral response to quinine, we assayed *inx-18(ok2454)*, *inx-19(ky634)* and *inx-19(tm1896)* mutant animals ([Fig 1A and 1B](#pgen.1008341.g001){ref-type="fig"}) for quinine sensitivity. We placed drops of quinine solution in front of freely crawling worms and recorded their responses as "responding" if they reverse or "non-responding" if they continue forward \[[@pgen.1008341.ref032], [@pgen.1008341.ref045]\]. We found that these mutant animals were hypersensitive to 1 mM quinine in the quinine drop test ([Fig 1C](#pgen.1008341.g001){ref-type="fig"}). As a negative control, we examined the response of mutant animals to M13 buffer. Both *inx-18(ok2454)* and *inx-19(tm1896)* animals responded to M13 buffer at similar levels to wild-type (N2) animals, *inx-19(ky634)* animals, however, were slightly more responsive than wild-type animals ([S1A Fig](#pgen.1008341.s001){ref-type="supplementary-material"}). This may be because this strain has mildly increased spontaneous reversal rates (see below). As a positive control, we tested the response of mutant animals to a high concentration of quinine (10 mM) that that is strongly aversive to wild-type animals. We found that that all strains respond similarly to presentation of 10 mM quinine ([S1B Fig](#pgen.1008341.s001){ref-type="supplementary-material"}). Together, these data show that *inx-18(ok2454)*, *inx-19(ky634)* and *inx-19(tm1896)*mutant animals have increased quinine avoidance, suggesting that ASH activity is increased in the absence of these electrical synapse components.

![Mutations in *inx-19* and *inx-18* result in hypersensitivity to quinine.\
A,B) Diagram of *inx-19* and *inx-18* alleles used. Innexin genes code for proteins that consist of 4 transmembrane helices with intracellular N and C tails. *Inx-19(ky634)* is a SNP resulting in an E\>K substitution within the first extracellular loop, while *inx-19(tm1896)* is an in-frame deletion of 546bp that removes most of the intracellular loop and a portion of the third transmembrane domain. *Inx-18(ok2454)* is a \~1800bp deletion that removes the second-fourth transmembrane domains and a portion of the C-terminus. C) Quinine Drop Test with 1 mM quinine. *Inx-19(ky634)*, *inx-19(tm1896)*, and *inx-18(ok2454)* mutant animals are hypersensitive to 1 mM quinine, responding a greater percentage of the time. N2 (wild-type) = 18%, n = 510; *inx-19(ky634)* = 65%, n = 120, p\<0.0001; *inx-19(tm1896)* = 44%, n = 390, p\<0.0001; *inx-18(ok2454)* = 44%, n = 350, p\<0.0001.](pgen.1008341.g001){#pgen.1008341.g001}

The *inx-19(tm1896*) allele alters quinine responses without affecting locomotion {#sec004}
---------------------------------------------------------------------------------

Two different *inx-19* alleles (*tm1896* and *ky634*) have been identified and implicated in sensory neuron function \[[@pgen.1008341.ref043]\]. While mutant animals with either allele show increased response to 1 mM quinine ([Fig 1C](#pgen.1008341.g001){ref-type="fig"}), these two alleles have different impacts on locomotion. First, *inx-19(ky634)* mutant animals exhibited more reversals in response to M13 ([S1A Fig](#pgen.1008341.s001){ref-type="supplementary-material"}). Second, during locomotion, *inx-19(ky634)* animals spontaneously reversed more frequently in the absence of stimuli ([S2A Fig](#pgen.1008341.s002){ref-type="supplementary-material"}). Third, the average crawling velocity of *inx-19(ky634)* mutant animals was lower than that of wild-type animals ([S2B Fig](#pgen.1008341.s002){ref-type="supplementary-material"}). These data suggest that *inx-19(ky634)* animals have altered movement in addition to changes in quinine response. At a molecular level, *inx-19(ky634)* is a G→A single nucleotide polymorphism causing an E70K substitution within the first extracellular loop of INX-19, while *inx-19(tm1896)* is a 546 basepair deletion that removes the majority of the first intracellular loop and a portion of the second transmembrane domain of INX-19 ([Fig 1A](#pgen.1008341.g001){ref-type="fig"}). Because the function of innexins requires their transmembrane domains, *tm1896* is likely to be a strong loss-of-function or null allele. By contrast, a substitution within the extracellular docking domain may have a more complicated effect on protein function. For this reason, *inx-19(tm1896)* animals were utilized for the remainder of the experiments.

*Inx-19* is required in both ASK and ASH for modulation of the quinine response {#sec005}
-------------------------------------------------------------------------------

*Inx-19* is expressed in multiple tissues such as neurons and muscles. Even within the nervous system, *inx-19* is expressed in ASH as well as a number of other neurons, including ASK, which has been implicated in quinine sensation and its regulation \[[@pgen.1008341.ref032], [@pgen.1008341.ref043], [@pgen.1008341.ref044]\]. To determine the site of action of INX-19, we performed a series of rescue experiments with *inx-19* cDNA fused to fluorphores in the *inx-19(tm1896)* background. We found that, under the control of the native *inx-19* promoter \[[@pgen.1008341.ref043]\], expression of *inx-19* cDNA fully rescued quinine hypersensitivity in response to 1 mM quinine ([Fig 2A](#pgen.1008341.g002){ref-type="fig"}). This demonstrates that *inx-19* cDNA is functional and the *inx-19* mutation is responsible for the quinine hypersensitivity phenotype. Interestingly, these worms also showed reduced response to 10 mM quinine, suggesting that INX-19 overexpression could cause over-correction of the quinine sensitivity defects ([S3A Fig](#pgen.1008341.s003){ref-type="supplementary-material"}).

![Expression of *inx-19* and *inx-18* in ASK and ASH restores wild-type quinine sensitivity.\
A) Expression of *inx-19* isoform A cDNA under the native promoter in *inx-19(tm1896)* animals rescued quinine sensitivity to N2 (wild-type) levels. Expression in ASK (*Psra-9*, which expresses solely in ASK \[[@pgen.1008341.ref046]\]) or ASH (*Posm-10*, which also expresses in the tail neurons PHA and PHB as well as weakly in ASI \[[@pgen.1008341.ref047], [@pgen.1008341.ref048]\]) alone did not significantly rescue the behavior, while simultaneous expression did. N2 = 15%, n = 220; *inx-19(tm1896)* = 46%, n = 210; *inx-19;Pinx-19*::*inx-19cDNA* = 18%, n = 100, p = 0.62 vs N2, p\<0.0001 vs *inx-19*; *inx-19;Psra-9*::*inx-19cDNA* = 32%, n = 100, p = 0.0009 vs N2, p = 0.02 vs *inx-19*; *inx-19;Posm-10*::*inx-19cDNA* = 37%, n = 110, p\<0.0001 vs N2, p = 0.13 vs *inx-19*; *inx-19;Psra-9*::*inx-19cDNA; Posm-10*::*inx-19cDNA* = 22%, n = 110, p = 0.16 vs N2, p\<0.0001 vs *inx-19*. B) Expression of *inx-18* gDNA in *inx-18(ok2454)* animals rescued the quinine hypersensitivity phenotype, as did expression of *inx-18* cDNA in ASK (*Psra-9*). N2 = 13%, n = 120; *inx-18(ok2454)* = 48%, n = 120; *inx-18;inx-18gDNA* = 12%, n = 100, p = 0.84 vs N2, p\<0.0001 vs *inx-18*; *inx-18;Psra-9*::*inx-18cDNA* = 14%, n = 120, p\>0.99 vs N2, p\<0.0001 vs *inx-18*.](pgen.1008341.g002){#pgen.1008341.g002}

We then expressed GFP or mCherry-tagged *inx-19* cDNA under the control of cell-selective promoters to determine in which neurons INX-19 acts to regulate quinine sensitivity. We found that expression of *inx-19* cDNA in either ASK or ASH (using *Psra-9* \[[@pgen.1008341.ref046]\] and *Posm-10* \[[@pgen.1008341.ref047], [@pgen.1008341.ref048]\], respectively) did not significantly restore the quinine response to 1 mM quinine in *inx-19(tm1896)* animals. In contrast, simultaneous expression of *inx-19* in both ASK and ASH brought 1 mM quinine response rates back to wild-type levels ([Fig 2A](#pgen.1008341.g002){ref-type="fig"}). As controls, we tested the response of these animals to M13 buffer and 10 mM quinine and found no change in sensitivity ([S3A and S3B Fig](#pgen.1008341.s003){ref-type="supplementary-material"}). These data indicate that INX-19 is required in both ASK and ASH for appropriate modulation of quinine sensitivity.

*Inx-18* is required in ASK for modulation of the quinine response {#sec006}
------------------------------------------------------------------

*Inx-18* is expressed in a subset of neurons including ASK \[[@pgen.1008341.ref008], [@pgen.1008341.ref044]\]. However, unlike *inx-19*, *inx-18* is not expressed in ASH, indicating that its site of action resides outside of ASH. To determine whether the altered quinine response rate of *inx-18* mutant animals is due to the lack of INX-18 function, we performed rescue experiments using *inx-18*. *Inx-18* does not have an obvious promoter, as several genes lie directly upstream of its genomic position. However, the second intron has been successfully used to drive its expression \[[@pgen.1008341.ref049]\]. To test whether the *inx-18(ok2454)* mutation is responsible for the quinine hypersensitivity phenotype, we cloned *inx-18* gDNA, which included the intronic regions. Expression of *inx-18* gDNA was sufficient to restore responses to 1 mM quinine in *inx-18(ok2454)* mutant animals to wild-type levels, indicating that loss of *inx-18* is the reason for quinine hypersensitivity ([Fig 2B](#pgen.1008341.g002){ref-type="fig"}). Next, we found that the site of action of *inx-18* is in ASK, as expression of *inx-18* cDNA fused to GFP using the *Psra-9* promoter rescued the quinine hypersensitivity phenotype ([Fig 2B](#pgen.1008341.g002){ref-type="fig"}). As controls, we tested the response of these animals to M13 buffer and 10 mM quinine and found no change in sensitivity ([S3C and S3D Fig](#pgen.1008341.s003){ref-type="supplementary-material"}). These results show that *inx-18* and *inx-19* have distinct, but partially overlapping, sites of action. Combined, our data indicate that INX-19 must be present in both ASK and ASH, while INX-18 in ASK alone is sufficient to modulate the quinine response.

ASK INX-19 and ASH INX-19 localize to the same regions in neighboring axons {#sec007}
---------------------------------------------------------------------------

The *C*. *elegans* wiring diagram suggests that the ASK and ASH neurons form electrical synapses with one another in the nerve ring \[[@pgen.1008341.ref041], [@pgen.1008341.ref042]\], which raises the possibility that INX-18 and INX-19 are components of these electrical synapses. As our behavioral results show that *inx-19* functions in both ASK and ASH, we examined the subcellular localization of INX-19 in these two neurons using fluorescence microscopy. We drove expression of GFP-tagged INX-19 in ASK and mCherry-tagged INX-19 in ASH. These fluorophore-tagged INX-19 constructs are functional as they can restore quinine responses in *inx-19(tm1896)* mutant animals ([Fig 2A](#pgen.1008341.g002){ref-type="fig"}). If INX-19 is a component of electrical synapses between ASK and ASH, we reasoned that INX-19 expressed in ASK would localize to the same regions of the nerve ring as INX-19 expressed in ASH. Our imaging data in wild type animals show that INX-19 forms punctate structures along the axons in the nerve ring when expressed in both cells. As expected, most ASK INX-19 and ASH INX-19 is localized to overlapping puncta, despite the fact that these innexin proteins are in two distinct neurons ([Fig 3A--3D](#pgen.1008341.g003){ref-type="fig"}). Quantification of these images show that INX-19 expressed in ASK and ASH produces puncta that colocalize 67% of the time ([Fig 3H](#pgen.1008341.g003){ref-type="fig"}). These data indicate that INX-19 is present on both sides of the ASK-ASH electrical synapses.

![INX-19 and INX-18 colocalize in the nerve ring when expressed in ASK and ASH.\
A) Diagram of the *C*. *elegans* head in a dorsal view. Dashed box indicates the location of imaging of ASK and ASH axons in the nerve ring. B-D) INX-19 expressed in both ASK (where it is tagged with GFP) (B) and ASH (where it is tagged with mCherry) (C) forms multiple puncta that colocalize along the ASK-ASH axons in wild-type animals. Points of colocalization are indicated with white arrowheads. ASK and ASH are additionally expressing cytosolic mTagBFP2, seen in the axons that traverse the image, highlighted in D. E-G) INX-19 tagged with mCherry expressed in ASH (E) colocalizes in the nerve ring with GFP-tagged INX-18 expressed in ASK in wild-type animals (F). A white arrowhead indicates a point of colocalization. Cytosolic BFP fills the ASK-ASH axons, highlighted in G. H) Quantification of colocalization. In worms expressing INX-19 in ASK and ASH, 67% of nerve ring puncta colocalize (n = 144 puncta in 14 animals). In worms expressing INX-18 in ASK and INX-19 in ASH, \~4% of nerve ring puncta colocalize (n = 81 puncta in 10 animals). Each dot represents an individual worm, and error bars are ±SEM.](pgen.1008341.g003){#pgen.1008341.g003}

INX-18 rarely colocalizes with INX-19 {#sec008}
-------------------------------------

Our behavioral results indicate that INX-18 functions within ASK to modulate the behavioral response to quinine. To investigate where INX-18 resides in ASK, and whether it is functioning in the same synapses as INX-19, we expressed GFP-tagged INX-18 and asked whether it colocalizes with INX-19 in wild-type animals (Fig[3E--3G](#pgen.1008341.g003){ref-type="fig"}). We found that, like INX-19, GFP-tagged INX-18 forms puncta along the axons ([Fig 3F](#pgen.1008341.g003){ref-type="fig"}). However, INX-18 showed low levels of colocalization with mCherry-tagged INX-19 expressed in ASH (\~4% colocalization, [Fig 3H](#pgen.1008341.g003){ref-type="fig"}), demonstrating that the vast majority of INX-18 is not in the same synapses as INX-19 in adult animals.

INX-19 localization in ASK requires both *inx-18* and *inx-19* {#sec009}
--------------------------------------------------------------

To determine the relationship between INX-18 and INX-19 localization, we investigated whether the expression patterns of INX-18 and INX-19 are influenced by one another. We expressed fluorescently-tagged *inx-18* and *inx-19* cDNA in ASK and ASH individually and examined their expression patterns in mutant backgrounds. We found that the number of INX-19 puncta in the ASK axon was significantly reduced in *inx-18* mutant animals ([Fig 4A](#pgen.1008341.g004){ref-type="fig"}). In addition, localization of INX-19 within ASK requires INX-19 in other neurons, as the number of ASK INX-19 puncta was diminished in *inx-19(tm1896)* mutant animals ([Fig 4A](#pgen.1008341.g004){ref-type="fig"}). In no cases were the puncta fully eliminated, indicating that only some electrical synapses are affected in each case. We did not observe significant differences in the number of INX-19 puncta in ASH in *inx-18(ok2454)* or *inx-19(tm1896)* animals, although the downward trend ([Fig 4B](#pgen.1008341.g004){ref-type="fig"}) suggests that INX-19 localization in ASH may need both *inx-18* and *inx-19*. In contrast, INX-18 localization does not appear to require INX-19, as the number of INX-18 puncta in the nerve ring remained unchanged in *inx-19(tm1896)* mutant animals ([Fig 4C](#pgen.1008341.g004){ref-type="fig"}). This indicates that the localization of INX-18 is independent of INX-19. Taken together, these data suggest that *inx-18* plays a role in INX-19 electrical synapse assembly and/or maintenance. Perhaps INX-18 is transiently present in the ASK-ASH synapses during development, but by adulthood INX-18 has been removed from these synapses. Indeed, a number of studies have shown that innexin expression can be developmentally contolled \[[@pgen.1008341.ref008], [@pgen.1008341.ref043], [@pgen.1008341.ref044]\].

![*inx-18* and *inx-19* play distinct roles in ASK-ASH electrical synapse localization and function.\
A) *inx-*19 cDNA was expressed using *Psra-9* and fluorescent puncta in the nerve ring were counted in N2 (wild-type), *inx-18(ok2454)* and *inx-19(tm1896)* backgrounds. Each dot represents an individual worm and error bars are ±SEM. Ordinary one-way ANOVA between three groups showed significant differences (F\[2,12\] = 5.763, p = 0.02, α = 0.05). Dunnett's multiple comparison test showed that INX-19 ASK puncta were decreased in *inx-18(ok2454)* (n = 5, p = 0.01) and in *inx-19(tm1896)* (n = 5, p = 0.05) in comparison to N2 (n = 5). B) *inx-*19 cDNA was expressed using *Psrd-10* and puncta in the nerve ring were counted in N2, *inx-18(ok2454)* and *inx-19(tm1896)* backgrounds. Each dot represents an individual worm and error bars are ±SEM. Ordinary one-way ANOVA between three groups showed no significant differences (F\[2,14\] = 0.814, p = 0.46, α = 0.05). C) *inx-*18 cDNA was expressed using *Psra-9* and puncta in the nerve ring were counted in N2, *inx-18(ok2454)* and *inx-19(tm1896)* backgrounds. Each dot represents an individual worm and error bars are ±SEM. Ordinary one-way ANOVA between three groups showed no significant differences (F\[2,13\] = 1.637, p = 0.23, α = 0.05). D) *Inx-18(ok2454);inx-19(tm1896)* double mutant animals were assayed for sensitivity to 1 mM quinine using the quinine drop test. Double mutants responded at higher rates than either *inx-18* or *inx-19* single mutants. N2 = 18%, n = 510; *inx-19(tm1896)* = 44%, n = 390; *inx-18(ok2454)* = 44%, n = 350; *inx-19;inx-18* = 53%, n = 180, p = 0.05 vs *inx-19*, p = 0.05 vs *inx-18*.](pgen.1008341.g004){#pgen.1008341.g004}

*Inx-18* and *inx-19* have largely overlapping functions {#sec010}
--------------------------------------------------------

To investigate the functional relationship between *inx-18* and *inx-19*, we assessed the behavioral responses of *inx-18; inx-19* double mutant animals. If these two genes act in parallel to regulate quinine sensitivity, the phenotype of the double mutant should be stronger than that of the single mutants. If, however, *inx-18* and *inx-19* are acting together in the same pathway, we would expect animals with mutations in both genes to have a phenotype of similar strength to the single mutant animals. The *inx-19(tm1896); inx-18(ok254)* double mutants responded at somewhat higher rates than both the *inx-18(ok2454)* and *inx-19(tm1896)* single mutants ([Fig 4D](#pgen.1008341.g004){ref-type="fig"}), but this difference was statistically insignificant. This suggests that the two genes function largely in the same pathway to modulate the quinine response. Together with the visualization data, these findings suggest that while INX-18 is localized to different electrical synapses than INX-19, its primary function is to set up or maintain INX-19 localization.

Three different possibilities for the function of the ASK-ASH electrical synapses in quinine regulation {#sec011}
-------------------------------------------------------------------------------------------------------

In order to determine how *inx-18* and *inx-19* affect ASH activity, we considered three potential mechanisms: First, *inx-18* and *inx-19* mutations may alter the cell fate of ASK or ASH, leading to changes in the quinine sensing circuit. Second, the ASK-ASH electrical synapses could function to shunt calcium, depressing ASH activity by allowing calcium ions to flow out to ASK. In this case, we expect that removal of ASK-ASH electrical synapses would result in increased Ca^2+^ signals in ASH and decreased Ca^2+^ levels in ASK. Finally, the ASK-ASH electrical synapses could pass cGMP from ASK to ASH, thus down-regulating the quinine response in ASH. Indeed, it was previously demonstrated that expressing the guanylyl cyclase GCY-27 in ASK rescued the quinine hypersensitivity in *gcy-27(ok3653)* mutant animals \[[@pgen.1008341.ref026]\], suggesting an important role of cGMP in ASK in modulating quinine responses. We tested these three possibilities by examining cell fate markers, the calcium indicator GCaMP6s, and the fluorescent cGMP reporter FlincG3 in ASK and ASH.

ASK and ASH cell fate and morphology are unchanged in *inx-19* and *inx-18* mutant animals {#sec012}
------------------------------------------------------------------------------------------

Electrical synapse channels are known to regulate cell fate decisions during development \[[@pgen.1008341.ref050], [@pgen.1008341.ref051]\], in particular, *inx-19* has been shown to regulate neural differentiation in *C*. *elegans* \[[@pgen.1008341.ref043]\]. Thus, it is possible that *inx-19* or *inx-18* also impacts ASK and/or ASH cell fate or morphology. To test this possibility, we expressed mCherry in ASK (using the *sra-9* promoter) and mTagBFP2 in ASH (using the *osm-10* promoter, which also expresses weakly in ASI). We found that the cell fate of ASK and ASH remained the same in the *inx-18(ok2454)* and *inx-19(tm1896)* mutant animals, as the number of neurons that expressed these fluorescent markers and their positions were unaltered ([Fig 5](#pgen.1008341.g005){ref-type="fig"}). Furthermore, we showed that the morphology of ASK and ASH were identical between wild-type and the mutant animals. Specifically, both ASK and ASH have cell bodies near the terminal bulb of the pharynx, while dendrites extend to the nose tip and axons project into the nerve ring. Additionally, the cell bodies, dendrites, and axons remained clearly visible In wild-type, *inx-19(tm1896)* and *inx-18(ok2454)* mutant animals ([Fig 5B](#pgen.1008341.g005){ref-type="fig"}). Together, these data indicate that there is no gross morphological or cell fate changes to either ASK or ASH upon removal of INX-18 and INX-19.

![ASK and ASH architecture is unaltered in *inx-18* and *inx-19* mutant animals.\
A) Diagram of neural architecture of ASK, ASH, and ASI in the *C*. *elegans* head. The dendrites reach out to the nose while the axons extend from the cell body into the nerve ring around the isthmus of the pharynx. B-D) Representative confocal images of the worm head with *Psra-9*::*mCherry* (ASK) and *Posm-10*::*bfp* (ASH and weakly in ASI) show cell bodies, dendrites extending to the nose, and axons projecting into the nerve ring. Images on the left include maximum intensity projections of the mCherry and BFP images superimposed upon a brightfield image to show location of cells; images on the right are maximum intensity projections of the mCherry and BFP channels without the brightfield image to show details of the cell architecture. Comparison between wild-type, *inx-19(tm1896)*, and *inx-18(ok2454)* (15--20 animals per genotype were imaged) show no major differences in cell architecture.](pgen.1008341.g005){#pgen.1008341.g005}

ASK calcium responses remain unchanged upon removal of ASK-ASH electrical synapses {#sec013}
----------------------------------------------------------------------------------

We examined the possibility that the ASK-ASH electrical synapses function to shunt calcium, thus decreasing behavioral responses to quinine. Previous studies have shown that the ASH neurons respond strongly to quinine with an increase in intracellular calcium \[[@pgen.1008341.ref027]\]. While ASK is known to be a minor player in the quinine response \[[@pgen.1008341.ref032]\], the calcium response of ASK neurons to quinine is unknown. In ASK, attractive stimuli typically result in a decrease in calcium levels, while the aversive stimulus SDS results in a calcium increase \[[@pgen.1008341.ref052]\]. Thus, it is possible that the aversive stimulus quinine also directly triggers a calcium increase in ASK. Alternatively, ASK may receive calcium ions from the primary quinine-sensing neuron ASH via the ASK-ASH electrical synapses. If the ASK-ASH electrical synapses pass calcium from ASH to ASK, this shunting effect would decrease ASH calcium levels in response to quinine as some of the calcium ions in ASH would flow to ASK in wild-type worms. In contrast, in animals lacking the ASK-ASH electrical synapses, we would expect increased calcium levels in ASH as the flow to ASK would be blocked. If ASK receives calcium from ASH, we would expect any quinine-induced calcium signal in ASK to decrease in mutant animals lacking the ASK-ASH electrical synapses.

We expressed GCaMP6s in ASK and ASH to visualize calcium dynamics in those cells in response to quinine presentation. Because both ASK and ASH are involved in blue-light avoidance behavior \[[@pgen.1008341.ref053]\], the GCaMP6s experiments were carried out in a *lite-1(ce314)* background to eliminate blue-light induced changes of GCaMP6s fluorescence in ASK and ASH. Our results showed that CGaMP6 fluorescence in ASK and ASH increased after switching from buffer to quinine, indicating increased Ca^2+^ levels in response to quinine ([Fig 6A and 6B](#pgen.1008341.g006){ref-type="fig"}, blue traces). However, Ca^2+^ signals in ASH were much more robust than those in ASK, consistent with the role of ASH as the primary quinine-sensing neuron \[[@pgen.1008341.ref032]\].

![ASK Ca^2+^ responses to quinine presentation are unaltered in *inx-18* and *inx-19* mutant animals while ASH Ca^2+^ responses are heightened in both.\
A) GCaMP6s fluorescence intensity in ASH in response to 10 mM quinine. Cells were imaged for 30s with presentation of quinine at 10s. The *lite-1(ce314)* mutation was included to eliminate blue-light induced calcium responses in ASK and ASH. All genotypes showed an increase in ASH GCaMP6s fluorescence in response to quinine presentation, though for *lite-1;inx-19(tm1896)* and *lite-1;inx-18(ok2454)* animals the response is larger and faster than that of *lite-1(ce314)*. Averaged GCaMP6s traces are shown and error bars are ±SEM. n = 48 animals for all genotypes tested. B) GCaMP6s fluorescence intensity in ASK in response to 10 mM quinine. ASK showed small increases of GCaMP6s signals and there were no significant differences between genotypes. Averaged GCaMP traces are shown and error bars are ±SEM. n = 24, n = 21 and n = 22 animals imaged for *lite-1(ce314)*, *lite-1;inx-19* and *lite-1;inx-18*, respectively. C, D) Heatmaps showing individual traces from all worms analyzed. Data points in the heatmaps represent GCaMP6s signals normalized to the averaged fluorescence intensity of the first 3 seconds of imaging. E) Quantification of ASH fluorescence change at four seconds after quinine stimulation. One-way ANOVA between three groups showed significant differences (F\[2,141\] = 3.89, p = 0.02, α = 0.05), and Dunnett's multiple comparison test showed that mean ASH GCaMP6s fluorescence change in *lite-1(ce314)* animals (n = 48) differed from both *lite-1;inx-19* (n = 48, p = 0.02) and *lite-1;inx-18* (n = 48, p = 0.05) animals. F) Quantification of ASK fluorescence change four seconds after quinine stimulation. One-way ANOVA between three groups showed no significant differences in ASK GCaMP6s fluorescence (F\[2,64\] = 0.202, p = 0.817, α = 0.05) between *lite-1(ce314)* (n = 24), *lite-1;inx-19* (n = 21) and *lite-1;inx-18* animals (n = 22).](pgen.1008341.g006){#pgen.1008341.g006}

To examine the impact of electrical synapses on Ca^2+^ dynamics, we monitored ASK and ASH GCaMP6s fluorescence in mutant *inx-18(ok2454)* and *inx-19(tm1896)* animals. We found that the increase in ASK GCaMP6s fluorescence remained the same between wild-type and mutant worms ([Fig 6B, 6D and 6F](#pgen.1008341.g006){ref-type="fig"}), suggesting that the ASK-ASH electrical synapses are not a main conduit for the ASK Ca^2+^ signal. When we imaged GCaMP6s fluorescence in ASH, we found the increase in ASH GCaMP6s fluorescence were enhanced in *inx-18 (ok2454)* and *inx-19(tm1896)* animals ([Fig 6A, 6C and 6E](#pgen.1008341.g006){ref-type="fig"}). These results are consistent with the behavioral quinine hypersensitivity observed in these mutant worms. Together, these data show that ASK Ca^2+^ signals do not rely on the ASK-ASH electrical synapses, indicating that Ca^2+^ shunting to ASK is not the primary mechanism of quinine response regulation.

cGMP levels in ASK and ASH are influenced by ASK-ASH electrical synapses {#sec014}
------------------------------------------------------------------------

cGMP is required within ASH for down regulation of the quinine response \[[@pgen.1008341.ref026]\]. Recently, two studies suggested that guanylyl cyclase expression in other neurons plays a key role in modulating the quinine response \[[@pgen.1008341.ref025], [@pgen.1008341.ref026]\]. These findings prompted us to examine whether ASH acquires cGMP through the ASK-ASH electrical synapses. Indeed, ASK expresses the guanylyl cyclases ODR-1 and GCY-27 \[[@pgen.1008341.ref054]\], both of which are known to modify the quinine response \[[@pgen.1008341.ref025], [@pgen.1008341.ref026]\]. If ASK supplies ASH with cGMP through the ASK-ASH electrical synapses, we would expect to observe diminished levels of cGMP in ASH with a compensatory increase within ASK in *inx-18(ok2454)* and *inx-19(tm1896)* mutant animals.

To visualize levels of cGMP within ASK and ASH, we utilized the *C*. *elegans* codon-optimized version of FlincG3, which contains the cGMP binding domains of protein kinase G1α fused to cpEGFP \[[@pgen.1008341.ref055], [@pgen.1008341.ref056]\]. Binding of cGMP increases FlincG3 fluorescence. We co-expressed FlincG3 and the red fluorescent protein mScarlet under control of the same promoters in ASK and ASH in the *lite-1(ce314)* background ([Fig 7A](#pgen.1008341.g007){ref-type="fig"}). After crossing the transgenes into *inx-18(ok2454)* and *inx-19(tm1896)*, we imaged FlincG3 fluorescence in ASK and ASH. FlincG3 fluorescence was compared to mScarlet fluorescence to account for variations in expression levels. We found that ASH FlincG3 fluorescence was decreased in both *inx-18(ok2454)* and *inx-19(tm1896)* mutant animals ([Fig 7B](#pgen.1008341.g007){ref-type="fig"}), suggesting a reduction of the basal cGMP levels in ASH. These data are consistent with the behavioral hyper-responsiveness of *inx-18* and *inx-19* mutant worms to dilute quinine, as decreased cGMP levels could lead to increased ASH calcium levels in response to quinine \[[@pgen.1008341.ref025], [@pgen.1008341.ref026]\]. In ASK, FlincG3 fluorescence was increased in *inx-19(tm1896)* mutant animals but was unchanged in *inx-18(ok2454)* animals ([Fig 7C](#pgen.1008341.g007){ref-type="fig"}), suggesting that INX-19-based electrical synapses are primarily responsible for supplying ASH with cGMP from ASK. Together, our data suggest that INX-18 and INX-19 are major components of the ASK-ASH electrical synapses that modulate behavioral sensitivity to quinine, and that they do so by affecting transport of cGMP into ASH.

![Mutations in *inx-18* and *inx-19* disrupt endogenous cGMP levels in ASK and ASH.\
A) Diagram of FlincG3. The cGMP binding domains of PKG 1α (blue) are followed by circularly permuted EGFP (green) and a short PKG 1α tail (blue). WingG2 increases in brightness in response to cGMP. B) Example of FlincG3 and mScarlet expression within ASH. Ellipses were drawn around the cell body to measure fluorescence intensity. C) cGMP levels within the ASH cell body. The ratio between mean fluorescence intensity of FlincG3 and mScarlet signals was determined for each genotype. Decreases in ASH FlincG3 fluorescence were found in *inx-18(ok2454)* and *inx-19(tm1896)* mutant animals when compared to wild-type worms. Each data point was obtained from a single cell; error bars are ±SEM. One-way ANOVA between three groups showed significant differences (F\[2,68\] = 3.643, p = 0.03, α = 0.05), and Dunnett's multiple comparison test showed that mean fluorescence intensity in *lite-1(ce314)* (n = 24) cells differed from both *lite-1;inx-18* cells (n = 24, p = 0.05) and *lite-1;inx-19* cells (n = 23, p = 0.04). D) cGMP levels within the ASK cell body. ASK FlincG3 fluorescence was not altered in *inx-18(ok2454)* mutant animals, and increased in *inx-19(tm1896)* mutant animals when compared to wild-type animals. Each data point was obtained from a single cell; error bars are ±SEM. One-way ANOVA between three groups showed significant differences (F\[2,72\] = 8.115, p = 0.0007, α = 0.05), and Dunnett's multiple comparison test showed that mean fluorescence intensity in *lite-1(ce314)* cells (n = 26) did not differ from *lite-1;inx-18* cells (n = 25, p = 0.87) but was increased in *lite-1;inx-19* cells (n = 24, p = 0.0008).](pgen.1008341.g007){#pgen.1008341.g007}

Discussion {#sec015}
==========

We showed that electrical synapses between the *C*. *elegans* sensory neurons ASK and ASH play an active role in modifying nociceptive behavior via the passage of cGMP between cells. We found that the innexins INX-18 and INX-19 are required within ASK and ASH for proper modulation of the quinine response, as mutant animals lacking these innexins are hyperresponsive to quinine. These innexins form electrical synapses between ASK and ASH, in which INX-19 is a major component, though INX-18 is important for correct localization of INX-19 synapses in ASK. Our study supports a model in which ASK-ASH electrical synapses facilitate the passage of cGMP from ASK to ASH. Within ASH, cGMP downregulates calcium signals in response to quinine stimulation, likely by binding to and activating the cGMP-dependent protein kinase EGL-4 \[[@pgen.1008341.ref026]\], ultimately leading to a reduction neural activity and thus aversive behavior ([Fig 8](#pgen.1008341.g008){ref-type="fig"}).

![Model of ASK-ASH electrical synapse facilitation of ASH modulation.](pgen.1008341.g008){#pgen.1008341.g008}

Our study supports a model in which ASK-ASH electrical synapses facilitate the passage of cGMP from ASK to ASH. Within ASH, cGMP downregulates calcium signals in response to quinine stimulation, leading to a reduction in aversive behavior. INX-19 (orange) is shown on both sides of the ASK-ASH electrical synapses while INX-18 (purple) is shown joining with an unknown innexin and contributing to INX-19-based synapse localization.

Electrical synapses can be made of different combinations of innexin subunits. Homotypic channels contain hemichannels that are composed of the same innexins, while heterotypic channels are made up of hemichannels that are composed of different innexins. The channel composition determines permeability, as heterotypic channels are thought to produce rectified electrical synapses: those that preferentially pass ions and small molecules in one direction rather than equally in both \[[@pgen.1008341.ref057]--[@pgen.1008341.ref059]\]. Our data suggest that INX-19 is a major component of the ASK-ASH electrical synapses. One possibility is that INX-19 forms homotypic channels. However, some INX-19 synapses do contain INX-18, suggesting that at least some are heterotypic. Though the number of electrical synapses containing both INX-18 and INX-19 is quite small, it is possible that levels of INX-18 within such synapses are generally low, making their visualization difficult. INX-18 could also make electrical synapses with other innexins in ASH. Nonetheless, our results suggest that the main function of INX-18 is carried out through its regulation of INX-19, as the *inx-18* and *inx-19* mutants do not show additive responses to 1mM quinine.

The structural makeup of the ASK-ASH electrical synapses has functional implications for ASH modulation. The composition of electrical synapses is key in determining their permeability of small molecules (such as Ca^2+^ and cGMP), and heterotypic composition is a major cause of rectification \[[@pgen.1008341.ref057], [@pgen.1008341.ref059]--[@pgen.1008341.ref061]\]. If the ASK-ASH electrical synapses are heterotypic (*i*.*e*., consist of both INX-18 and INX-19 hemichannels) and rectified, this could explain why ASK cGMP levels, but not calcium levels, are affected by *inx-18* and *inx-19* mutations. Rectified channels bias the direction of movement of ions and molecules, making it more likely for signals to travel in one direction. If small molecule signals could easily pass from ASK to ASH but not in the reverse direction, cGMP may be more likely to travel from ASK to ASH than Ca^2+^ would be from ASH to ASK. This mechanism could explain why our data suggest movement of cGMP but not Ca^2+^. Additionally, the permeability of electrical synapses is dependent on the subunits that make up the channels \[[@pgen.1008341.ref017], [@pgen.1008341.ref062]\]. While the permeability of most innexin-based channels is unknown, it is possible that the ASK-ASH electrical synapses are more permeable to cGMP than Ca^2+^, particularly given the timescales upon which each operate. Electrical synapses have long been considered low-pass filters, preferentially passing signals that change over longer time periods as opposed to quick oscillations \[[@pgen.1008341.ref063], [@pgen.1008341.ref064]\]. Regardless of the molecular reason, the selectivity of electrical synapses to either particular molecules or directions means that they can be sophisticated players within neural circuits. Changes in innexin composition during development or in mature circuits could dramatically impact how the neurons are regulated through the electrical synaptic network.

Electrical synapses are not static structures; they are regulated developmentally as well as in mature circuits \[[@pgen.1008341.ref044], [@pgen.1008341.ref063], [@pgen.1008341.ref065]--[@pgen.1008341.ref067]\]. Our data suggest that innexins can impact the localization of other innexins even if they are not a permanent part of the same synapses. INX-18 plays a crucial role in the localization of INX-19. Thus, its main impact on modulating the quinine response may be in supporting the function of INX-19. While INX-18 is required for proper localization of INX-19, an *inx-18* mutation does not eliminate INX-19 synapses completely. This may explain why the *inx-18(ok2454)* mutation does not have an impact on cGMP levels in ASK, as some signaling could still occur through the remaining INX-19-based electrical synapses even in the absence of INX-18.

ASH activity is modulated by cGMP, and yet ASH is not known to express any guanylyl cyclases, which produce cGMP \[[@pgen.1008341.ref054], [@pgen.1008341.ref068], [@pgen.1008341.ref069]\]. This suggests that other neurons may regulate its activity. Such modulation occurs in the context of a larger sensory neuron network that simultaneously assesses many different sensory inputs, any of which could be affecting baseline levels of cGMP within sensory neurons. Thus, by being sensitive to changes in cGMP levels, ASH is able to receive modulatory information from many neurons simultaneously. ASH receives cGMP from its immediate neighbor ASK as well as other neurons \[[@pgen.1008341.ref025]\], suggesting that cGMP levels within ASH (and thus nociceptive sensitivity) are under the control of a number of external signals. If this is the case, cGMP could be a general signal of the state of the worm, integrating multiple signals to indicate whether it is in a favorable or unfavorable circumstance \[[@pgen.1008341.ref070]--[@pgen.1008341.ref074]\]. Our data support the notion that electrical synapses regulate function in a sensory neuron network by modulating the passage of small molecules into neurons such as ASH. In this way, multiple sensory inputs such as availability of food or sexual partners, presence of pathogens or other environmental conditions could alter various different behaviors at once.

Materials and methods {#sec016}
=====================

*C*. *elegans* culture {#sec017}
----------------------

Strains were maintained at room temperature (20--21°C) on NGM agar plates seeded with OP50 *E*. *coli* bacteria. The N2 strain (Bristol, England) was used as wild type. The following mutant strains were used in this study: CX6161 *inx-19 (ky634) I*, FX01896 *inx-19 (tm1896) I*, RB1896 *inx-18 (ok2454) IV*, BJH2183 *inx-18 (ok2454) IV;inx-19(tm1896) I*, BJH2259 *lite-1 (ce314) X*, BJH2304 *lite-1(ce314);inx-19(tm1896)*, *and* BJH2303 *lite-1(ce314);inx-18(ok2454)*.

Transgenes {#sec018}
----------

Transgenic strains for rescue experiments were generated by microinjection \[[@pgen.1008341.ref075]\] of various innexin-containing plasmids (30--40 ng/μl) together with co-injection markers ([Table 1](#pgen.1008341.t001){ref-type="table"}). The co-injection markers were *Punc-122*::*gfp* (BJP-I15, 20--40 ng/μl) and *Punc-122*::*mcherry* (BJP-I14, 30--40 ng/μl). Cytoplasmic fluorophores (mCherry, mTagBFP2, and mScarlet) were injected at 30-40ng/μl. For GCaMP imaging experiments, plasmids (BJP-L136, *Psrbc-66*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr* or BJP-L137, *Posm-10*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr*) were injected at 70 ng/μl into the light-insensitive *lite-1(ce314)* worms. To quantify cGMP levels, FlincG3 plasmids (pFG270, *Psrbc-66*::*FlincG3*::*unc-54utr* or pFG250, *Psrd-10*::*FlincG3*::*unc-54utr*) were injected at 20 ng/μl into *lite-1(ce314)* worms.

10.1371/journal.pgen.1008341.t001

###### DNA constructs.

![](pgen.1008341.t001){#pgen.1008341.t001g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Name       Construct                                               Construction Notes
  ---------- ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
  BJP-L109   *Pinx-19*::*inx-19a*::*gfp*::*unc-54utr*                *Pinx-19* (5556bp) is from Dr. Cornelia Bargmann and primers were: GATAAGCGCGGATGCTCCT and TGACAGTGCTCTCAGAGGGA.\
                                                                     *Inx-19a* cDNA is from Dr. Cornelia Bargmann and primers were: ATGTGGCGGACACCAGCATC and AAGAAACGATTTCGTCTGTCCAGGA.

  BJP-I15    *Punc-122*::*gfp*::*unc-54utr*                          

  BJP-L99    *Psra-9*::*inx-19a*::*mCherry*::*gdp-2utr*              *Psra-9* is 3012bp and primers were: GCATGCTATATTCCACCAAA and GAAATCTTGAAACTGAAAAATACA

  BJP-L112   *Psra-9*::*inx-19a*::*gfp*::*unc-54utr*                 

  BJP-L125   *Psra-6*::*inx-19a*::*mCherry*::*gdp-2utr*              *Psra-6* is 2018bp and primers were TTCCAGTGCTCTGAAAATCTTG and GGCAAAATCTGAAATAATAAATATT

  BJP-L114   *Posm-10*::*inx-19a*::*gfp*::*unc-54utr*                *Posm-10* (900bp) is from Dr. Josh Kaplan and primers were: CTTGACACCGACTGGCAC and GCGTTCGACACCTTGTAAGAT

  BJP-L120   *Psrd-10*::*inx-19a*::*gfp*::*unc-54utr*                *Psrd-10* (1841bp) is from Dr. Denise Ferkey and primers were: AGCCACGGCTAGCTACAG and GTTGAATTTGGTCTGTGAGCT

             *inx-18 gDNA PCR*                                       *Inx18* gDNA (7646bp) used the primers: ACAGTCGAGTCGTCGTCGTCG and TAATTTTGAAACAAAAATCGGAAAGAA

  BJP-L46    *Psra-9*::*inx-18*::*gfp*::*unc-54utr*                  *Inx-18* cDNA (1308bp) is from Dr. Zhao-Wen Wang and primers were: ATGGTCGGTGGATTCCG and AACATAATGTGTCCGTGTCGGA

  BJP-L115   *Psrbc-66*::*mTagBFP2*::*unc-54utr*                     *Psrbc-66* is 2055bp and used the primers: CAACGATGAAATATTGATCGTACAAA and TTCTGAGACACCTGACTTTCTGTC

  BJP-L116   *Posm-10*::*mTagBFP2*::*unc-54utr*                      

  BJP-L143   *Psrbc-66*::*mScarlet*::*unc-54utr*                     

  BJP-L142   *Psrd-10*::*mScarlet*::*unc-54utr*                      

  BJP-L139   *Psra-9*::*mCherry*::*unc-54utr*                        

  BJP-L136   *Psrbc-66*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr*   

  BJP-L137   *Posm-10*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr*    

  pFG270     *Psrbc-66*::*FlincG3*::*unc-54utr*                      Received from Dr. Denise Ferkey

  pFG250     *Psrd-10*::*FlincG3*::*unc-54utr*                       Received from Dr. Denise Ferkey
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Behavioral assays {#sec019}
-----------------

Well-fed day 1 adults were used for all analyses. To ensure uniformity of worm age and feeding status, L4 animals were picked onto fresh plates the afternoon before behavior tests. Behavior assays were performed on at least 5 separate days in parallel with controls.

Quinine drop test {#sec020}
-----------------

The quinine drop test was performed as described previously \[[@pgen.1008341.ref031], [@pgen.1008341.ref032], [@pgen.1008341.ref045]\]. Quinine HCl (Sigma-Aldrich Q1125) was dissolved in M13 Buffer pH 7.4 (30 mM Tris-HCl pH 7.0, 100 mM NaCl, 10 mM KCl) to 10 mM. Aliquots were frozen at -20°C. Aliquots were defrosted on the day of the experiment and allowed to reach room temperature before use. Solutions were loaded into glass needles via mouth pipetting through long silicone tubing. Needles were formed from 1.5 mm filamented glass capillaries (World Precision Instruments, Inc.) with a Sutter micropipette puller and the tips opened by breaking with fine forceps. 10cm NGM plates were brought to room temperature on the bench overnight and then left open at room temperature to dry for 2.5--4 hours before being used (plates are appropriately dry when worms leave tracks on the agar that do not immediately disappear). For each assay, 15 worms were placed on a plate and allowed to acclimate for 30 min. Small drops (approximately 1 body length in diameter) of M13, 1 mM quinine, or 10 mM quinine were then delivered via glass needle approximately 1 body length in front of worms. When worms encountered the drop, they were scored as avoiding the drop if they initiated a reversal within 4 s and reversed at least half a body length backwards. To avoid desensitization, worms were not tested with a new solution within 2min of initial drop presentation. The experimenter was blind to the strain when scoring reversals. All rescues except for *inx-18* gDNA were performed with C-terminal mCherry- or GFP-tagged INX-19 or INX-18 and expression was verified visually before behavioral experiments. All groups were compared with a Chi-square test and post-hoc Fisher's Exact tests with Bonferroni's correction were computed to compare groups

Movement assays {#sec021}
---------------

Five worms at a time were placed on 10 cm NGM plates and allowed to acclimate for 1 minute. Video capturing was then carried out using an imaging set up from MBF Bioscience. Freely crawling worms were monitored for 60 seconds at 5 frames per second. Moving velocity at each frame was calculated by the WormLab 4.1 from MBF Bioscience after confirming correct assignment of head location throughout the video. Reversals were denoted with negative values. Comparison of number of reversals/min and mean velocity was calculated using an ordinary one-way ANOVA using Dunnett's correction for multiple comparisons between all groups. The alpha value was set at 0.05.

Confocal microscopy for imaging synapse and cell architecture {#sec022}
-------------------------------------------------------------

Young adults were paralyzed using 30 mg/ml 2,3-butanedione monoxime (BDM) dissolved in M9. Worms were imaged using an Olympus FV1000 confocal system with a 60x oil objective (NA 1.4). Z-stacks of fluorescent images (0.40 μm step-size for synapses, or 1.20 μm step-size for cell architecture) were taken at the region of interest. Maximum intensity projections of images were obtained using Fiji. For colocalization analysis, mTagBFP2 was cytoplasmically expressed in ASK and ASH in order to visualize axons. The number of INX-18 and INX-19 puncta within mTagBFP2-expressing ASH and ASK axons in the nerve ring was counted. Puncta were scored as colocalizing (containing signal from both channels) or non-colocalizing (containing signal from a single channel). Percentage colocalization was calculated by determining the ratio between the number of colocalizing puncta and the total number of puncta in each maximum intensity projection.

Calcium imaging {#sec023}
---------------

GCaMP6s \[[@pgen.1008341.ref076]\] was used for all calcium imaging. *Lite-1(ce314)* worms were injected with either *Psra9*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr* (ASK) or *Posm-10*::*GCaMP6s*::*SL2*::*mCherry*::*let-858utr* (ASH) along with the co-injection marker *Punc-122*:*mCherry*. Transgenic lines were crossed with mutant animals to generate *lite-1(ce314);inx-19(tm1896)* and *lite-1(ce314);inx-18(ok2454)*, which the identical extrachromosomal arrays for imaging. Worms were imaged using a microfluidic olfactory chip \[[@pgen.1008341.ref077]\]. M13 buffer was used to load worms into the chip, and their nose tips were washed with M13 buffer for 30 seconds before each recording. At the start of the recording, animals were exposed to M13 buffer for 10 s before 10 mM Quinine dissolved in M13 was washed in to the chip. The images were captured at 5 frames per second with an exposure time of 100ms on a Leica DMI3000B inverted microscope with a 63x Oil objective and a QImaging OptiMOS camera. The region of interest was defined as a square-shaped area surrounding the desired cell body. Background-subtracted fluorescence intensity values were collected from every sample's ROI and stored into MATLAB formatted files. Change in fluorescence intensity (ΔF/F%) was calculated by dividing each value by the average intensity of the first 3 seconds of imaging.

cGMP imaging {#sec024}
------------

FlincG3 \[[@pgen.1008341.ref055], [@pgen.1008341.ref056]\] was used for cGMP imaging. *Lite-1(ce314)* worms were injected with either *Psrbc-66*::*FlincG3*::*unc-54utr* and *Psrbc-66*::*mScarlet*::*unc-54utr* (ASK) or *Psrd-10*::*FlincG3*::*unc-54utr* and *Psrd-10*::*mScarlet*::*unc-54utr* (ASH) along with the co-injection marker *Punc-122*:*mCherry*. Transgenic lines were crossed with mutant animals to generate *lite-1(ce314);inx-19(tm1896)* and *lite-1(ce314);inx-18(ok2454)*, which carry the identical extrachromosomal arrays for imaging. L4 worms were picked onto fresh OP50-seeded NGM plates 6 hours before imaging to ensure synchronization of age and feeding status. Young adults were paralyzed with 30 mg/ml BDM dissolved in M9. Immobilized worms were imaged using an Olympus FV1000 confocal microscope with a 60x Water objective. Kalman filtering was used to reduce noise. Z-stacks (1.28 μm step-size) were taken through the cell body. Maximum intensity projections were obtained using Fiji \[[@pgen.1008341.ref078]\]. Two elliptical ROIs were drawn in the mScarlet channel: one surrounding the cell body and one capturing background fluorescence from a region near the cell body that did not contain an axon or dendrite. Mean pixel intensity in both the FlincG3 and mScarlet channels was calculated using Fiji and background intensity was subtracted from cell body intensity. The ratio between FlincG3 and mScarlet mean intensity was calculated to control for expression variation.

Statistical analyses {#sec025}
--------------------

Statistical analyses for all experiments except calcium imaging were carried out as described in the legends for each figure using GraphPad Prism Statistical analysis of the calcium imaging experiments was carried out using a custom written MATLAB program and GraphPad Prism.

Supporting information {#sec026}
======================

###### *inx-18* and *inx-19* mutant animals respond normally to control solutions.

**A)** *Inx-19(tm1896)* and *inx-18(ok2454)* mutant animals respond at N2 (wild-type) levels when presented with M13 buffer, while *inx-19(ky634)* animals respond slightly more than wild-type animals. N2 = 13%, n = 330; *inx-19(ky634)* = 23%, n = 120, p = 0.012; *inx-19(tm1896)* = 19%, n = 210, p = 0.07; *inx-18(ok2454)* = 16%, n = 160, p = 0.33. **B)** *Inx-19(ky634)*, *inx-19(tm1896)*, and *inx-18(ok2454)* mutant animals respond at wild-type levels when presented with 10 mM quinine. N2 = 93%, n = 330; *inx-19(ky634)* = 97%, n = 120, p = 0.18; *inx-19(tm1896)* = 97%, n = 210, p = 0.03; *inx-18(ok2454)* = 98%, n = 120, p = 0.02.

(TIF)

###### 

Click here for additional data file.

###### *inx-19(ky634)* mutant animals have movement defects.

**A)** *Inx-19(ky634)* mutant animals reverse more frequently than N2 (wild-type) animals. Number of reversals were counted from a one-minute video. One-way ANOVA between three groups showed significant differences (F\[2,99\] = 6.943, p = 0.0015, α = 0.05), and Dunnett's multiple comparison test showed that N2 (n = 34) differed from *inx-19(ky634)* (n = 33, p = 0.0006) but not *inx-19(tm1896)*(n = 35, p = 0.097). **B)** *Inx-19(ky634)* mutant animals have lower average movement velocity than N2 animals. One-way ANOVA between three groups showed significant differences (F\[2,99\] = 6.089, p = 0.003, α = 0.05), and Dunnett's multiple comparison test showed that N2 (n = 34) differed from *inx-19(ky634)* (n = 33, p = 0.021) but not *inx-19(tm1896)*(n = 35, p = 0.677). Each data point represents a single worm and error bars are ±SEM.

(TIF)

###### 

Click here for additional data file.

###### Responses of worms carrying rescue transgenes to negative and positive control solutions.

**A)** *Inx-19(tm1896)* animals carrying rescue transgenes behaved like N2 (wild-type) animals when presented with M13 buffer. N2 = 14%, n = 220; *inx-19(tm1896)* = 19%, n = 210; *inx-19;Pinx-19*::*inx-19cDNA* = 10%, n = 100; *inx-19;Psra-9*::*inx-19cDNA* = 10%, n = 100; *inx-19;Posm-10*::*inx-19cDNA* = 11%, n = 110; *inx-19;Psra-9*::*inx-19cDNA; Posm-10*::*inx-19cDNA* = 10%, n = 110. **B)** *Inx-18(ok2454)* animals carrying rescue transgenes behaved like N2 animals when presented with M13 buffer. N2 = 12%, n = 120; *inx-18(ok2454)* = 7%, n = 120; *inx-18;inx-18gDNA* = 4%, n = 100; *inx-18;Psra-9*::*inx-18cDNA* = 9%, n = 120. **C)** *Inx-19(tm1896)* animal carrying neuron-specific transgenes behaved like N2 animals when presented with 10 mM quinine, but expression of *inx-19* cDNA using the native promoter reduced the responses to 10 mM quinine below wild-type levels. N2 = 96%, n = 220; *inx-19(tm1896)* = 97%, n = 210; *inx-19;Pinx-19*::*inx-19cDNA* = 85%, n = 100, p = 0.002 vs N2, p = 0.0004 vs *inx-19*; *inx-19;Psra-9*::*inx-19cDNA* = 91%, n = 100, p = 0.10 vs N2, p = 0.04 vs *inx-19*; *inx-19;Posm-10*::*inx-19cDNA* = 97%, n = 110, p = 0.76 vs N2, p\>0.99 vs *inx-19*; *inx-19;Psra-9*::*inx-19cDNA; Posm-10*::*inx-19cDNA* = 96%, n = 110, p\>0.99 vs N2, p = 0.74 vs *inx-19*. **D)** When expressing *inx-18* cDNA under the native promoter or in ASK, *inx-18(ok2454)* animals behaved like wild-type when presented with 10 mM quinine. N2 = 97%, n = 120; *inx-18(ok2454)* = 95%, n = 120; *inx-18;inx-18gDNA* = 91%, n = 100; *inx-18;Psra-9*::*inx-18cDNA* = 91%, n = 120.

(TIF)

###### 

Click here for additional data file.

###### Archive of raw data for figures.

(XLSX)

###### 

Click here for additional data file.
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\* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. \*

Dear Dr Bai,

Thank you very much for submitting your Research Article entitled \'INX-18 and INX-19 play distinct roles in electrical synapses that modulate aversive behavior in Caenorhabditis elegans\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some aspects of the manuscript that should be improved.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1\) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2\) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our [archive](http://www.plosgenetics.org/article/browse/volume). If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Coleen T. Murphy

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: In this manuscript, Lisa et al investigate the physiological function of electrical synapses in behavioral modulation in C. elegans. The authors have combined genetic manipulation, morphological analysis, behavioral test and imaging analysis to clearly show that the electrical synapses, including both INX-18 and INX-19, between two sensory neurons (ASH and ASK) modulate the quinine induced aversive response in ASH by controlling cGMP redistribution. This article provide a novel insight into the molecular basis for the the bias communication of intracellular signal cGMP between sensory neurons. Also, the article show that electrical synapses with different components have distinct roles in controlling cGMP levels in ASK and ASH. All experiments are well designed, and result provide strong support for their conclusion, so I am happy to support the paper published on Plos Genetics with minor changes.

Minor Comments:

1: The result shows that electrical synapses composed by inx-19 is permeable for cGMP, but not Ca2+. Is it possible the molecular different between inx-18 and inx-19 contribute to the permeability difference? Please comment.

2: The figure legends have lots of redundant information, especially for statistical analysis. It is better to put them in the method.

3: Unless I missed, I did not find which transgenic animals were used for fig 3.

4: The ASH promoter (osm-10) used in the paper also weakly expresses in ASI neuron, so it is possible that fluorescence disturb from ASI mess up the imaging single from ASH, especially for INX-19 puncta calculation in fig 3. Although I believe that the strong INX-19 fluorescence signalling comes from ASH based on my experience, it will be much clearer if the author clarify it in the manuscript.

5: In Fig 6 A and B, the marker of Y-axis, the change in fluorescence, is not clear. I believe it should be the percentage change based on GCaMP intensity calculation if I am correct. So please clarify it.

Reviewer \#2: This manuscript from the Bai group addresses the role of electrical synapses in avoidance behavior. The manuscript investigates two genes inx-19 and inx-19, which are expressed in two different sensory neurons ASH and ASK.

The authors postulate that expression of the two proteins in necessary in the different sensory neurons for the communication to occur.

This is an excellent manuscript and I recommend the publication of the manuscript without any changes!

the experiments are well conducted with the appropriate controls.

I do have a couple of queries that I hope the authors can address:

1\. the inx-19 allele (ky634) seems like a pleiotropic allele. IS the sensory responses to quinine in this allele due to its movement defects. Have the authors tested any other deterrents and do they observe similar locomotory defects.

2\. Does the inx-19 puncta also show differences in the two different alleles ky634 and tm1896? This is not a suggestion of a new experiment but just a curiosity to know if different alleles elicit differences in expression.

3\. Have the authors tested different concentrations of the quinine on the double mutant inx-19;inx-18?

I want to congratulate the authors of a great well written story and manuscript!

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: None

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Jie Liu

Reviewer \#2: No
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Dear Dr Bai,

We are pleased to inform you that your manuscript entitled \"INX-18 and INX-19 play distinct roles in electrical synapses that modulate aversive behavior in Caenorhabditis elegans\" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.

In the meantime, please log into Editorial Manager at <https://www.editorialmanager.com/pgenetics/>, click the \"Update My Information\" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Coleen T. Murphy

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

[www.plosgenetics.org](http://www.plosgenetics.org)

Twitter: \@PLOSGenetics
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Comments from the reviewers (if applicable):

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: The authors have addressed my concerns with the previous submission. I recommend an accept without any further changes.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: None

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No
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**Data Deposition**

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the [Dryad Digital Repository](http://www.datadryad.org). As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our [website](http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories).

The following link will take you to the Dryad record for your article, so you won\'t have to re‐enter its bibliographic information, and can upload your files directly: 

<http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-19-01262R1>

More information about depositing data in Dryad is available at <http://www.datadryad.org/depositing>. If you experience any difficulties in submitting your data, please contact <help@datadryad.org> for support.

Additionally, please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Press Queries**

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.
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Dear Dr Bai,

We are pleased to inform you that your manuscript entitled \"INX-18 and INX-19 play distinct roles in electrical synapses that modulate aversive behavior in *Caenorhabditis elegans*\" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Matt Lyles
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